{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:05:38Z","timestamp":1791353138066,"version":"4.3.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.exphem.2012.09.002","type":"journal-article","created":{"date-parts":[[2012,9,14]],"date-time":"2012-09-14T03:11:12Z","timestamp":1347592272000},"page":"67-78.e4","source":"Crossref","is-referenced-by-count":87,"title":["Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma"],"prefix":"10.1016","volume":"41","author":[{"given":"Kejie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archito T.","family":"Tamayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Shacham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kauffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhishuo","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan V.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2012.09.002_bib1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/00000478-199008000-00007","article-title":"Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations","volume":"14","author":"Lardelli","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.exphem.2012.09.002_bib2","first-page":"515","article-title":"The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors","volume":"1","author":"Levine","year":"1992","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.exphem.2012.09.002_bib3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1200\/JCO.2008.16.8435","article-title":"Improvement of overall survival in advanced stage mantle cell lymphoma","volume":"27","author":"Herrmann","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2012.09.002_bib4","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/annonc\/mdn045","article-title":"Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies","volume":"19","author":"Martin","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.exphem.2012.09.002_bib5","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/j.1460-2075.1994.tb06488.x","article-title":"Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene","volume":"13","author":"Bodrug","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2012.09.002_bib6","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1083\/jcb.108.4.1195","article-title":"Higher order chromosome structure is affected by cold-sensitive mutations in a Schizosaccharomyces pombe gene crm1+ which encodes a 115-kD protein preferentially localized in the nucleus and its periphery","volume":"108","author":"Adachi","year":"1989","journal-title":"J Cell Biol"},{"key":"10.1016\/j.exphem.2012.09.002_bib7","doi-asserted-by":"crossref","first-page":"29742","DOI":"10.1074\/jbc.272.47.29742","article-title":"Molecular cloning and cell cycle-dependent expression of mammalian CRM1, a protein involved in nuclear export of proteins","volume":"272","author":"Kudo","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2012.09.002_bib8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0092-8674(00)80370-0","article-title":"Exportin 1 (Crm1p) is an essential nuclear export factor","volume":"90","author":"Stade","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2012.09.002_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1749-6632.1999.tb09397.x","article-title":"Trichostatin and leptomycin. Inhibition of histone deacetylation and signal-dependent nuclear export","volume":"886","author":"Yoshida","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.exphem.2012.09.002_bib10","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1126\/science.1064693","article-title":"Delineation of mRNA export pathways by the use of cell-permeable peptides","volume":"294","author":"Gallouzi","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.exphem.2012.09.002_bib11","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1074\/jbc.C200620200","article-title":"Leptomycin B, an inhibitor of the nuclear export receptor CRM1, inhibits COX-2 expression","volume":"278","author":"Jang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2012.09.002_bib12","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/emboj\/18.6.1660","article-title":"A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking","volume":"18","author":"Stommel","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2012.09.002_bib13","doi-asserted-by":"crossref","first-page":"10636","DOI":"10.1128\/MCB.24.24.10636-10649.2004","article-title":"The CRM1 nuclear export receptor controls pathological cardiac gene expression","volume":"24","author":"Harrison","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2012.09.002_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbrc.2005.04.109","article-title":"Akt1 contains a functional leucine-rich nuclear export sequence","volume":"332","author":"Saji","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2012.09.002_bib15","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/jcb.20876","article-title":"Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 and CRM1","volume":"98","author":"Lo","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.exphem.2012.09.002_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mc.20156","article-title":"Nuclear translocation of the pro-apoptotic Bcl-2 family member Bok induces apoptosis","volume":"45","author":"Bartholomeusz","year":"2006","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.exphem.2012.09.002_bib17","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1101\/gad.12.10.1453","article-title":"Regulation of the fission yeast transcription factor Pap1 by oxidative stress: requirement for the nuclear export factor Crm1 (Exportin) and the stress-activated MAP kinase Sty1\/Spc1","volume":"12","author":"Toone","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2012.09.002_bib18","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.bcp.2011.12.016","article-title":"Nuclear export of proteins and drug resistance in cancer","volume":"83","author":"Turner","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.exphem.2012.09.002_bib19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2174\/0929867033457791","article-title":"Nucleo-cytoplasmic transport of proteins as a target for therapeutic drugs","volume":"10","author":"Yashiroda","year":"2003","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.exphem.2012.09.002_bib20","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.2174\/092986708786242859","article-title":"CRM1-mediated nuclear export of proteins and drug resistance in cancer","volume":"15","author":"Turner","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.exphem.2012.09.002_bib21","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/ijc.22591","article-title":"Selective induction of apoptosis by leptomycin B in keratinocytes expressing HPV oncogenes","volume":"120","author":"Gray","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2012.09.002_bib22","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/1078-0432.CCR-08-0124","article-title":"A new fork for clinical application: targeting forkhead transcription factors in cancer","volume":"15","author":"Yang","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2012.09.002_bib23","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/nrd2759","article-title":"Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways","volume":"7","author":"Dey","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.exphem.2012.09.002_bib24","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1073\/pnas.96.16.9112","article-title":"Leptomycin B inactivates CRM1\/exportin 1 by covalent modification at a cysteine residue in the central conserved region","volume":"96","author":"Kudo","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2012.09.002_bib25","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/bjc.1996.415","article-title":"Phase I trial of elactocin","volume":"74","author":"Newlands","year":"1996","journal-title":"Br\u00a0J Cancer"},{"key":"10.1016\/j.exphem.2012.09.002_bib26","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1158\/0008-5472.CAN-08-0858","article-title":"Identification of nuclear export inhibitors with potent anticancer activity in\u00a0vivo","volume":"69","author":"Mutka","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2012.09.002_bib27","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1182\/blood-2005-10-4042","article-title":"Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas","volume":"107","author":"Fu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.09.002_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4049\/jimmunol.171.1.88","article-title":"Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis","volume":"171","author":"Pham","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2012.09.002_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/ng1532","article-title":"Reverse engineering of regulatory networks in human B cells","volume":"37","author":"Basso","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2012.09.002_bib30","first-page":"232","article-title":"CRM1\/XPO1 represents a promising therapeutic target for treatment of chronic lymphocytic leukemia","volume":"118","author":"Lapalombella","year":"2011","journal-title":"ASH Annual Meeting Abstracts"},{"key":"10.1016\/j.exphem.2012.09.002_bib31","first-page":"1852","article-title":"CRM1 Is highly expressed in myeloma plasma cells and its inhibition byKPT-SINE induces cytotoxicity by increasing p53 in the nucleus of multiple myeloma (MM) cells","volume":"118","author":"Kandarpa","year":"2011","journal-title":"ASH Annual Meeting Abstracts"},{"key":"10.1016\/j.exphem.2012.09.002_bib32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/emboj\/16.4.807","article-title":"The human homologue of yeast CRM1 is in a dynamic subcomplex with CAN\/Nup214 and a novel nuclear pore component Nup88","volume":"16","author":"Fornerod","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2012.09.002_bib33","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1158\/0008-5472.CAN-09-0484","article-title":"Human multiple myeloma cells are sensitized to topoisomerase II inhibitors by CRM1 inhibition","volume":"69","author":"Turner","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2012.09.002_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1042\/BST0350012","article-title":"Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy","volume":"35","author":"Goldberg","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.exphem.2012.09.002_bib35","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1073\/pnas.97.3.1014","article-title":"A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB\/IkappaBalpha complexes","volume":"97","author":"Huang","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2012.09.002_bib36","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/ijc.24146","article-title":"The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation","volume":"124","author":"van der Watt","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2012.09.002_bib37","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/cncr.23354","article-title":"Expression of the nuclear export protein chromosomal region maintenance\/exportin 1\/Xpo1 is a prognostic factor in human ovarian cancer","volume":"112","author":"Noske","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2012.09.002_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2012.09.002_bib39","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.bmcl.2010.03.049","article-title":"The cytotoxic styryl lactone goniothalamin is an inhibitor of nucleocytoplasmic transport","volume":"20","author":"Wach","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.exphem.2012.09.002_bib40","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1021\/ja9097093","article-title":"Anguinomycins and derivatives: total syntheses, modeling, and biological evaluation of the inhibition of nucleocytoplasmic transport","volume":"132","author":"Bonazzi","year":"2010","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.exphem.2012.09.002_bib41","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood-2011-01-333138","article-title":"CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity","volume":"118","author":"Sakakibara","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.09.002_bib42","doi-asserted-by":"crossref","first-page":"9487","DOI":"10.1016\/j.bmc.2008.09.051","article-title":"Inhibition of the CRM1-mediated nucleocytoplasmic transport by N-azolylacrylates: structure-activity relationship and mechanism of action","volume":"16","author":"Van Neck","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.exphem.2012.09.002_bib43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1535-6108(03)00303-9","article-title":"A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells","volume":"4","author":"Kau","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2012.09.002_bib44","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nrc906","article-title":"Transcription factors as targets for cancer therapy","volume":"2","author":"Darnell","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2012.09.002_bib45","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1182\/blood.V96.7.2537","article-title":"Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells","volume":"96","author":"Keller","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.09.002_bib46","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1073\/pnas.100119497","article-title":"NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells","volume":"97","author":"Cahir-McFarland","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2012.09.002_bib47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1073\/pnas.91.1.28","article-title":"Autoregulation of I kappa B alpha activity","volume":"91","author":"Chiao","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 3","key":"10.1016\/j.exphem.2012.09.002_bib48","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1242\/jcs.110.3.369","article-title":"Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm","volume":"110","author":"Arenzana-Seisdedos","year":"1997","journal-title":"J Cell Sci"},{"key":"10.1016\/j.exphem.2012.09.002_bib49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1158\/1541-7786.42.3.1","article-title":"Inhibition of IkappaBalpha nuclear export as an approach to abrogate nuclear factor-kappaB-dependent cancer cell survival","volume":"3","author":"O'Connor","year":"2005","journal-title":"Mol Cancer Res"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X12003839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X12003839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T18:58:23Z","timestamp":1687719503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X12003839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0301472X12003839"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2012.09.002","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}